| DNA replication |
2.28 |
0.00e+0 |
34/36 (94.44%) |
RNASEH2A;RPA2;PCNA;...
|
| Ribosome biogenesis in eukaryotes |
2.26 |
0.00e+0 |
52/108 (48.15%) |
NXT1;IMP3;NHP2;...
|
| Ribosome |
2.17 |
0.00e+0 |
113/158 (71.52%) |
RPL10;RPS5;MRPS12;...
|
| Mismatch repair |
2.13 |
0.00e+0 |
22/23 (95.65%) |
RPA2;PCNA;MLH1;...
|
| Spliceosome |
2.12 |
0.00e+0 |
101/150 (67.33%) |
EIF4A3;PRPF8;SRSF7;...
|
| Cytosolic DNA-sensing pathway |
1.90 |
2.94e-3 |
52/63 (82.54%) |
POLR3K;PYCARD;POLR2H;...
|
| TNF signaling pathway |
1.85 |
8.81e-3 |
103/112 (91.96%) |
CCL2;CASP10;VCAM1;...
|
| RNA degradation |
1.83 |
9.91e-3 |
53/79 (67.09%) |
MTREX;LSM8;PFKP;...
|
| Fanconi anemia pathway |
1.83 |
8.81e-3 |
36/54 (66.67%) |
RPA2;PALB2;MLH1;...
|
| RNA polymerase |
1.80 |
1.32e-2 |
23/31 (74.19%) |
POLR3K;POLR2H;POLR2I;...
|
| RNA transport |
1.77 |
1.36e-2 |
128/186 (68.82%) |
NXT1;EIF4A3;RPP38;...
|
| Base excision repair |
1.76 |
1.62e-2 |
29/33 (87.88%) |
APEX1;PCNA;PARP1;...
|
| Malaria |
1.76 |
1.56e-2 |
44/50 (88%) |
CCL2;VCAM1;COMP;...
|
| Viral protein interaction with cytokine and cytokine re... |
1.75 |
1.45e-2 |
84/100 (84%) |
CCL2;TNFSF10;CXCL1;...
|
| Proteasome |
1.72 |
1.82e-2 |
44/46 (95.65%) |
PSMA7;PSMB6;PSMB4;...
|
| N-Glycan biosynthesis |
1.71 |
1.93e-2 |
38/50 (76%) |
ST6GAL1;MGAT4A;MAN1A1;...
|
| IL-17 signaling pathway |
1.70 |
2.02e-2 |
84/94 (89.36%) |
CCL2;CXCL1;CXCL5;...
|
| Coronavirus disease |
1.69 |
2.06e-2 |
215/232 (92.67%) |
CCL2;C3;F13A1;...
|
| Graft-versus-host disease |
1.69 |
2.04e-2 |
32/42 (76.19%) |
IL6;IL1B;HLA-DRB1;...
|
| Influenza A |
1.68 |
2.11e-2 |
156/172 (90.7%) |
CCL2;TMPRSS4;TNFSF10;...
|
| Progesterone-mediated oocyte maturation |
1.67 |
2.31e-2 |
75/100 (75%) |
BUB1;CDC25A;PRKACB;...
|
| Mucin type O-glycan biosynthesis |
1.65 |
2.64e-2 |
20/36 (55.56%) |
GCNT3;C1GALT1C1;GALNT14;...
|
| Caffeine metabolism |
1.64 |
2.57e-2 |
5/6 (83.33%) |
NAT1
|
| Herpes simplex virus 1 infection |
1.64 |
2.61e-2 |
165/498 (33.13%) |
CCL2;C3;SRSF7;...
|
| Folate biosynthesis |
1.62 |
3.42e-2 |
23/26 (88.46%) |
AKR1C3;AKR1B10;AKR1B1;...
|
| Cell cycle |
1.61 |
3.35e-2 |
110/124 (88.71%) |
SMAD3;MYC;ESPL1;...
|
| Homologous recombination |
1.59 |
4.08e-2 |
35/41 (85.37%) |
RPA2;PALB2;RPA3;...
|
| Inflammatory bowel disease |
1.58 |
4.37e-2 |
58/65 (89.23%) |
SMAD3;IFNGR1;IL6;...
|
| Oxytocin signaling pathway |
-1.62 |
5.00e-2 |
128/154 (83.12%) |
ADCY8;PRKACA;PPP1CB;...
|
| Melanoma |
-1.62 |
4.81e-2 |
68/72 (94.44%) |
EGF;AKT3;GADD45G;...
|
| Metabolism of xenobiotics by cytochrome P450 |
-1.63 |
4.44e-2 |
49/77 (63.64%) |
ADH5;UGT2B17;UGT2B28;...
|
| Glioma |
-1.66 |
3.80e-2 |
67/75 (89.33%) |
EGF;AKT3;GADD45G;...
|
| Tyrosine metabolism |
-1.67 |
3.70e-2 |
30/36 (83.33%) |
TAT;TYR;ADH1C;...
|
| Gastric acid secretion |
-1.67 |
3.72e-2 |
63/76 (82.89%) |
PLCB1;CCKBR;ADCY8;...
|
| Glycine, serine and threonine metabolism |
-1.68 |
3.75e-2 |
31/40 (77.5%) |
CBS;PHGDH;SARDH;...
|
| Porphyrin and chlorophyll metabolism |
-1.70 |
2.81e-2 |
23/43 (53.49%) |
COX15;UGT2A3;HEPH;...
|
| Butanoate metabolism |
-1.71 |
2.70e-2 |
23/28 (82.14%) |
HADHA;AACS;ACAT1;...
|
| Drug metabolism |
-1.74 |
2.39e-2 |
78/151 (51.66%) |
ADH5;UGT2B17;FMO5;...
|
| Mineral absorption |
-1.74 |
2.50e-2 |
48/60 (80%) |
TRPM6;SLC34A2;ATP7A;...
|
| PPAR signaling pathway |
-1.74 |
2.73e-2 |
66/74 (89.19%) |
SLC27A2;CYP27A1;CPT2;...
|
| Bile secretion |
-1.81 |
1.56e-2 |
68/90 (75.56%) |
SLC5A1;SLCO1A2;ATP1B3;...
|
| Ascorbate and aldarate metabolism |
-1.82 |
1.11e-2 |
15/30 (50%) |
KL;ALDH9A1;AKR1A1;...
|
| Valine, leucine and isoleucine degradation |
-1.86 |
5.55e-3 |
42/48 (87.5%) |
HADHA;AACS;ACAT1;...
|
| Terpenoid backbone biosynthesis |
-1.90 |
4.76e-3 |
18/22 (81.82%) |
ICMT;ACAT1;MVK;...
|
| Fatty acid degradation |
-1.92 |
1.85e-3 |
40/43 (93.02%) |
ACAT1;ALDH9A1;ACOX3;...
|
| Steroid biosynthesis |
-1.93 |
2.22e-3 |
19/20 (95%) |
SC5D;TM7SF2;DHCR24;...
|
| Primary bile acid biosynthesis |
-2.03 |
0.00e+0 |
15/17 (88.24%) |
SLC27A5;SCP2;CYP39A1;...
|
| Complement and coagulation cascades |
-2.03 |
0.00e+0 |
76/85 (89.41%) |
C8A;F2;MBL2;...
|
| Peroxisome |
-2.05 |
0.00e+0 |
72/82 (87.8%) |
PEX5L;DECR2;EPHX2;...
|
| Biosynthesis of unsaturated fatty acids |
-2.14 |
0.00e+0 |
21/27 (77.78%) |
ACOX3;ACOX1;SCP2;...
|
